Newark, New Castle, USA, June 07, 2023 (GLOBE NEWSWIRE) — The market analysis of the global minimally invasive spine technologies market was conducted by Growth Plus Reports in 2022 and is valued at US$ 3.01 billion. The market is expected to hit a revenue CAGR of 7.5% to reach US$ 5.77 billion by 2031.
Research in the global market for minimally invasive spine technologies indicates that during the forecast period, revenue share is likely to increase significantly.
The global Minimally Invasive Spine Technologies Market is poised for significant revenue growth during the forecast period, driven by the increasing demand for less invasive surgical procedures and advancements in medical technology. A recently published market research report offers a comprehensive analysis of the current trends, market drivers, challenges, and growth opportunities in the field of minimally invasive spine technologies.
Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/minimally-invasive-spine-technologies-market/8958
Minimally Invasive Spine Technologies Market Scope
|Market Size Value in 2022||US$ 3.01 billion|
|Revenue Forecast in 2031||US$ 5.77 billion|
|Base Year for Estimation||2022|
|Forecast Period||2023 to 2031|
|Segments Covered||Type, Indication, End User, and Region|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa|
Minimally invasive spine technologies involve innovative surgical techniques and tools that enable surgeons to perform spinal procedures with smaller incisions, reduced tissue trauma, and quicker recovery times for patients. These technologies have gained immense popularity due to their potential benefits, including decreased blood loss, reduced post-operative pain, shorter hospital stays, and improved patient outcomes.
The market research report highlights several factors contributing to the growth of the minimally invasive spine technologies market. Firstly, the increasing prevalence of spinal disorders, such as herniated discs, spinal stenosis, and degenerative disc diseases, has led to rising demand for effective treatment options with minimal invasiveness. Minimally invasive spine technologies offer a viable alternative to traditional open surgeries, attracting both patients and healthcare providers.
Secondly, advancements in medical technology and surgical techniques have shown a crucial role in driving market revenue growth. Innovations in imaging systems, navigation systems, surgical instruments, and implants have significantly improved the accuracy and safety of minimally invasive spine procedures. These technological advancements have expanded the range of treatable conditions and increased the acceptance of minimally invasive approaches among surgeons.
Furthermore, the growing geriatric population, more susceptible to spinal conditions, and the increasing preference for outpatient procedures have further fueled the demand for minimally invasive spine technologies. Moreover, the cost-effectiveness of these procedures, as they reduce hospitalization and post-operative care requirements, has garnered attention from healthcare providers and payers.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/minimally-invasive-spine-technologies-market/8958
Recent Development in the Minimally Invasive Spine Technologies Market:
- In March 2022, in a single treatment, Accelus merged the technologies of their Remi Robotic Navigation, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device.
A list of the prominent players operating in the global market for minimally invasive spine technologies includes:
- Boston Scientific Corporation
- Globus Medical Inc.
- Johnson & Johnson
- Medtronic Plc
- NuVasive, Inc.
Based on type, the global minimally invasive spine technologies market is segmented into percutaneous pedicle screw-rod fixation, trans-sacral fixation, translaminar and trans facet screws, and cervical fixation.
Based on indication, the global minimally invasive spine technologies market is segmented into a herniated disc, degenerative disc disease, lumber spinal stenosis, spinal deformities, spinal infection and instability, spinal tumors, and vertebral-compression fractures.
Based on end-user, the global minimally invasive spine technologies market is segmented into hospitals, orthopedic clinics, and ambulatory surgical centers.
Hospitals account for the largest revenue share of the global market in terms of minimally invasive spine technologies market forecast.
Global market research on the minimally invasive spine technologies market was done in-depth by Growth Plus Reports. We looked at the core market traits, noteworthy investment prospects, regional growth trends, ten-year revenue projections, rival market participants, and mergers and acquisitions.
Table of Content
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- Regulatory Landscape
- Reimbursement Scenario
- MARKET DYNAMICS
- GLOBAL MINIMALLY INVASIVE SPINE TECHNOLOGIES MARKET – ANALYSIS & FORECAST, BY TYPE
- Percutaneous Pedicle Screw-Rod Fixation
- Trans-sacral Fixation
- Translaminar and Trans Facet Screws
- Cervical Fixation
- GLOBAL MINIMALLY INVASIVE SPINE TECHNOLOGIES MARKET – ANALYSIS & FORECAST, BY INDICATION
- Herniated Disc
- Degenerative Disc Disease
- Lumber Spinal Stenosis
- Spinal Deformities
- Spinal Infection and Instability
- Spinal Tumors
- Vertebral-compression Fractures
- GLOBAL MINIMALLY INVASIVE SPINE TECHNOLOGIES MARKET – ANALYSIS & FORECAST, BY END USER
- Orthopedic Clinics
- Ambulatory Surgical Centers
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8958
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at – https://www.growthplusreports.com/report-store
Browse more latest healthcare reports:
Nummular Eczema Treatment Market by Drug Class (Immunomodulators, Antibiotics, Antihistamines), Route of Administration (Topical, Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Global Outlook & Forecast 2023-2031
Mirvetuximab Soravtansine Market by Indication (Ovarian Cancer, Fallopian Tube Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Marine Nutraceuticals Market by Product (Omega-3 Fatty Acids, Fucoidan, Seaweeds), Application (Dietary Supplements, Pharmaceuticals), Form (Softgel Capsules, Powders, Liquid), Distribution Channel (Hypermarkets, Specialty Retail Stores) – Global Outlook & Forecast 2023-2031
Adenosquamous Carcinoma Treatment Market by Indication (Breast Cancer, Lungs Cancer), Treatment Regime (Monotherapy, Combination Therapy), Therapy (Chemotherapy, Immunotherapy) – Global Outlook & Forecast 2023-2031
Adenosine Deaminase Inhibitors Market by Type (Pentostatin, Elapegademase), Application (Chronic Lymphocytic Leukemia, Hairy Cell Leukemia) – Global Outlook & Forecast 2023-2031
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.
Manan Sethi Director, Market Insights Email: email@example.com 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web: https://www.growthplusreports.com/